Company Filing History:
1 out of 1,745 
1 out of 18 
1 out of 5,094 
Years Active: 2017
Title: Jean-Patrick Joly: Innovator in Cancer Treatment
Introduction
Jean-Patrick Joly is a notable inventor based in Nice, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Jean-Patrick Joly holds a patent for benzene sulfonamide thiazole compounds. The present invention relates to a compound of general formula (1) wherein R represents C-Caryl comprising one or two fused rings. In this compound, from 2 to 5 carbon atoms may be replaced with a heteroatom selected from O, S, and NR. Additionally, it may be substituted with from 5 to 11 substituents selected from R, halo, CN, NO, CF, OCF, COOR, OCOR, SONRR, CONRR, NRR, NRCOR, (CH)—NRR, (CH)—OR, and (CH)SR. The compounds are also noted for their potential use in treating various cancers.
Career Highlights
Throughout his career, Jean-Patrick Joly has worked with esteemed institutions such as the National Institute of Health and Medical Research and the University of Nice Sophia Antipolis. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Stephane Rocchi and Robert Ballotti. Their collaborative efforts have further advanced the research and development of innovative compounds in the medical field.
Conclusion
Jean-Patrick Joly's contributions to cancer treatment through his patented compounds highlight his role as an influential inventor in the field of medicinal chemistry. His work continues to inspire advancements in healthcare and the development of effective treatments for cancer.